glp 1 drugs and parkinson's disease GLP-1 Disease: New Clues in Neurodegeneration Glucagon-like peptide-1 - Wikipedia

Any references to overlapping pathway activity are included solely for scientific context and do not imply that the blend is intended to heal, regenerate, or treat any condition

Heres the whole thing in plain terms: What they did: built and validated a lab-grade method to accurately measure 5A1MQ in the blood, then dosed rats two ways intravenous (IV) and oral and tracked exactly how much showed up in circulation over time

in 1996, compared to a few seconds for endogenous -MSH

These findings suggest its potential to inhibit cancer growth, reduce tumor burden, and improve survival, making it a promising anti-cancer agent